Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T&T Trial: Testosterone + Tamoxifen in Male Breast Cancer
NCT05156606Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of testosterone, sponsored by University Medical Center Groningen. Primary endpoint: Safety profile at 1 year. Started Nov 2022; status: terminated.
02
Drugs
testosterone
Beyond the preview
Go deeper on NCT05156606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05156606.